IRIDEX CORP Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
IRIDEX CORP (IRIX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent of -0.60% for the 12-month period ending 2017-12-30, per its 10-K filed 2018-03-14.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2018-03-14
- IRIDEX CORP effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2017 was -0.60%.
- IRIDEX CORP effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2016 was -3.00%, a 108.62% decline from fiscal 2016.
- IRIDEX CORP effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2016 was 34.80%, a 1238.46% increase from fiscal 2015.
- IRIDEX CORP effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2015 was 2.60%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month as first filed |
|---|---|---|
| 2017-12-30 | -0.60% 10-K · filed 2018-03-14 | |
| 2016-12-31 | -3.00% 10-K · filed 2018-03-14 | |
| 2016-01-02 | 34.80% 10-K · filed 2018-03-14 | |
| 2015-01-03 | 2.60% 10-K · filed 2017-03-15 | -2.60% 10-K · filed 2015-04-02 |
| 2013-12-28 | 0.00% 10-K · filed 2016-03-31 | |
| 2012-12-29 | 0.00% 10-K · filed 2015-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |